Inhaled insulin could be a better option than injections or pumps for some patients with type 1 diabetes, a new clinical trial shows. About 21% of those on inhaled insulin had a hemoglobin A1C ...
Dublin, April 01, 2025 (GLOBE NEWSWIRE) -- The "Needle Free Diabetes Care Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
Cipla, a global name in inhalation therapies, has announced the launch of Afrezza, the world’s only rapid-acting inhaled insulin, in India. The drug is approved for adults with type 1 and type 2 ...
There are approximately 425 million people worldwide with diabetes. Approximately 75 million of these inject themselves with insulin daily. Now, they may soon have a new alternative to syringes or ...
Lee Calladine pricks his skin with a needle up to eight times a day to give himself an injection of insulin – the hormone that keeps his type 1 diabetes in check. Without insulin, his blood-sugar ...
Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Needle Free Diabetes Care Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Needle Free Diabetes Care Market ...
In 1,647 Framingham adults, closer MIND diet adherence was linked to slower gray matter loss over about 12 years. See the foods, MRI data, and limitations. Virginia's new nursing home sanctions ...
Diabetes rates continue to rise, with 11.7 million Canadians living with diabetes or pre-diabetes. At UBC, scientists have created a pain-free drug delivery method to help people with diabetes manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results